We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-42.00 | -0.39% | 10,700.00 | 10,702.00 | 10,704.00 | 10,780.00 | 10,698.00 | 10,756.00 | 392,122 | 14:05:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 27.86 | 165.93B |
Date | Subject | Author | Discuss |
---|---|---|---|
16/3/2021 14:02 | Some of the amateur shorts will have taken a bath today, very silly. AZN trading at a level which ascribes 0 value to any COVID future revenues, which whilst a pandemic is ongoing are not on commercial terms in any case. Unfortunately some may have difficulty relating to this. AZN = an oncology play, at least before the Alexion deal completes. | essentialinvestor | |
16/3/2021 14:00 | Yup, you can look at current consensus 2 yesrs out, tells the same story. | essentialinvestor | |
16/3/2021 13:56 | BARCELONA (Agefi-Dow Jones) - According to Jefferies, AstraZeneca's revenue and profit trajectory is compelling compared to that of its largely capitalized European counterparts. The quality of earnings and cash flow generation of the British pharmaceutical giant are improving while the trajectory of earnings per share is considered "impressive" by Jefferies who raises its recommendation on the title from "hold" to "buy". According to the investment bank, the $ 37 billion transaction to acquire Alexion also has strategic advantages for AstraZeneca. The acquisition will allow the company to enter the "attractive" rare disease segment and it will also develop its ability to fund greater R&D spending and maximize the value of its pipeline, according to Jefferies. In London, the AstraZeneca share gains 3.2% to 72.04. | beckers2008 | |
16/3/2021 13:15 | I think this is due to Brexit, EU trying to get their own back.Unfortunately the damage is done and the reputation of AZN is on the line.Bad play EU.! | umitw | |
16/3/2021 12:49 | #4342 Indeed. The irony is, if anyone looks at this purely from a statistical viewpoint (so ignoring the complete lack of any known scientific mechanism that could possibly link the two), you'd have to conclude (comparing incidence with vaccine, against population at large) the vaccine makes you LESS likely to have a blood clot. | bluemango | |
16/3/2021 12:46 | The biggest problem the EU have with the OxfordAZ vaccine, it's BRITISH | mr hangman | |
16/3/2021 12:39 | Do they tell us everything ? | philanderer | |
16/3/2021 12:29 | What evidence are all these countries' experts seeing that the WHO/EMA/MRHA/AZN/ETC I heard someone on the TV/radio say that (a) blood clot frequencies were exactly the same as with the pfizer jabs, and (b) were actually slightly lower than the population at large. | thamestrader | |
16/3/2021 11:09 | Sweden halts AstraZeneca vaccine use | philanderer | |
16/3/2021 10:58 | EI, nice trade, well done. -------------------- I thought theyd given it the thumbs up ? WHO’s global advisory committee on vaccine safety will hold a meeting on Tuesday, while the European Medicines Agency (EMA) will also meet, with a view to publishing further guidance on Thursday. Yahoo Finance | philanderer | |
16/3/2021 10:16 | I'm sitting on last week's purchases for the moment, but that can change at any moment... | imastu pidgitaswell | |
16/3/2021 10:12 | This could be the reason for part of the rise JEFFERIES RAISES ASTRAZENECA TO 'BUY' (HOLD) - PRICE TARGET 8,850 (8,250) PENCESold my two short term buys today as documented on this board at 7205Still hold my larger holding for the longer term | triple witcher | |
16/3/2021 10:08 | Lovely result on Friday and yesterday's buys, sold some. | essentialinvestor | |
16/3/2021 10:03 | Amid all the vaccine hysteria, does anyone have a suggestion why the share price is up 200+? | imastu pidgitaswell | |
16/3/2021 07:27 | SNG I mean. Good old karma is now at work with the jab. | abeygale | |
16/3/2021 07:24 | Not taking the vaccine is a victory over loosing out on shares like NTYC and SYM last year. I expect most lucky holders are now not so lucky after having the jab. It's all about karma for their ill gotten gains profiting hundreds of millions between them out of this pandemic. It is ethically wrong, and all the blame was pushed onto eBay and Amazon traders, | abeygale | |
16/3/2021 07:15 | This is a tad over an hr. worth watching fully when you have time. He is very professional, and very pro vac, and explains sars2/vac in easy to understand terms. | games | |
16/3/2021 06:52 | With many more EU countries now stopping the use of the AZN vaccine including all the big names like Germany France Holland Spain Italy Portugal Ireland we are not far away from the whole of the EU taking a negative stance V this company This at a time when the EU needs vaccines in arms like there was no tomorrow as case numbers rise alarmingly AZN has become a political football imo and is being used by Brussels who did the ordering for the whole bloc --- making a balls of it --- and now looking for a scapegoat to hang the blame on Unfortunately in this time of wave number 4 washing into the EU penalty box , such political posturing looks set to delay the EU vaccine roll out by many months at a time when it needed the pedal to the metal buywell fears that the backwash of this football match will be a bad result --- in that the current and new variants will beat the present untweaked vaccine by the time the whistle is blown Plus extra time will be needed now to tweak new vaccine versions There will be no winners The Vaccine Wars have arrived | buywell3 | |
16/3/2021 00:41 | May be of interest: | essentialinvestor | |
16/3/2021 00:32 | UK experts say there will be a big increase in the number of people being offered Covid vaccinations in the coming days. The increase has been made possible by a large shipment of the Oxford-AstraZeneca vaccine from the Serum Institute in India BBC | philanderer | |
15/3/2021 22:39 | so many people on here having the jab...i think you are a bunch of liars or ridiculously stupid | johncasey | |
15/3/2021 22:06 | Tick yes you will be asked about any unexplained bleeding or bruising. From memory on one particular blood thinning medicine it needs to be checked a person is up-to-date, can't remember which one that is. | essentialinvestor | |
15/3/2021 21:58 | Of course everything said and done by politicians is political - just look at what our politicians go on about. From what has come out so far even if there is a blood clot issue, it appears to be a very small one. I had the jab today and it just occurred to me that one of the questions was - are you on any blood thinners? - is that a reaction to the clot issue? I have no doubts that the risk is a small one - like any vaccines there can be a reaction and the chances of being hit badly by covid are massively greater than any vaccine risk. Sadly this will put more people off getting a vaccine - it will cost people their lives and hold back the control of the disease. If only people were better educated on risk (and generally). | cheshiremoggie | |
15/3/2021 19:54 | If interested see todays BUY thread post ====== Vaccines and Blood Clots --- is there a problem ? ====== | buywell3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions